Stock listing
NASDAQ:ARWR Arrowhead Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Arrowhead Pharmaceuticals, Inc.
Follow Arrowhead Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ARWR
$59.20 USD +1.97 (+3.4%)
Delayed at least 15 minutes · 11:30 AM EDT, Oct 20, 2026
- Day range so far
- $56.92 – $59.57 USDDelayed at least 15 minutes · 11:30 AM EDT, Oct 20, 2026
- Volume
- 557,815 sharesDelayed at least 15 minutes · 11:30 AM EDT, Oct 20, 2026
- Market value
- $8.36B USDDelayed at least 15 minutes · 11:30 AM EDT, Oct 20, 2026 · price × 141.3M shares outstanding
- 52-week range
- $36.73 – $95.49 USDLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ARWR · Home | $59.20 USD | +1.97 (+3.4%) | 557,815 | $56.93 | $59.57 | $56.92 | $57.23 | Delayed 15+ min · 11:30 AM EDT, Oct 20, 2026 |
| B3:A2RR34 | 36.00 BRL | -0.80 (-2.2%) | 26 | 36.00 | 36.00 | 36.00 | 36.80 | Close on Oct 19, 2026 |
| LSE:0HI3 | $56.85 USD | +0.53 (+0.9%) | 169 | $56.05 | $57.50 | $56.05 | $56.32 | Close on Oct 19, 2026 |
| Frankfurt:HDP1 | €50.84 EUR | +1.13 (+2.3%) | — | €49.67 | €50.84 | €49.67 | €49.71 | Close on Oct 19, 2026 |
| Munich:HDP1 | €50.88 EUR | -1.46 (-2.8%) | — | €50.88 | €50.88 | €50.88 | €52.34 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:ARWR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $57.23 | +1.33 | +2.4% | $56.96 | $57.30 | $56.05 | 1,646,984 | |
| $55.90 | -2.60 | -4.4% | $58.45 | $58.45 | $55.83 | 1,772,800 | |
| $58.50 | +0.13 | +0.2% | $58.50 | $59.40 | $57.40 | 2,009,600 | |
| $58.37 | +0.24 | +0.4% | $58.48 | $60.53 | $57.15 | 4,160,100 | |
| $58.13 | -2.60 | -4.3% | $60.04 | $60.73 | $58.08 | 2,260,400 | |
| $60.73 | -2.02 | -3.2% | $62.49 | $62.50 | $60.48 | 1,194,400 | |
| $62.75 | +2.01 | +3.3% | $60.72 | $62.99 | $60.44 | 2,765,700 | |
| $60.74 | -0.74 | -1.2% | $60.54 | $61.13 | $59.21 | 1,784,700 | |
| $61.48 | -0.06 | -0.1% | $61.63 | $62.75 | $60.78 | 1,819,200 | |
| $61.54 | -0.81 | -1.3% | $62.86 | $63.19 | $60.56 | 1,675,500 | |
| $62.35 | -1.84 | -2.9% | $64.76 | $64.76 | $62.22 | 2,249,400 | |
| $64.19 | -0.60 | -0.9% | $65.57 | $66.16 | $63.99 | 1,487,600 | |
| $64.79 | -0.66 | -1.0% | $65.00 | $65.76 | $64.50 | 1,521,700 | |
| $65.45 | -0.80 | -1.2% | $66.80 | $66.80 | $65.09 | 1,742,700 | |
| $66.25 | +0.79 | +1.2% | $65.46 | $66.83 | $64.57 | 2,869,600 | |
| $65.46 | -0.46 | -0.7% | $65.00 | $66.11 | $63.99 | 1,589,700 | |
| $65.92 | -0.15 | -0.2% | $66.50 | $67.44 | $65.40 | 1,616,200 | |
| $66.07 | -0.89 | -1.3% | $67.00 | $67.45 | $65.46 | 1,626,300 | |
| $66.96 | -4.90 | -6.8% | $72.16 | $72.49 | $66.27 | 2,554,500 | |
| $71.86 | +3.07 | +4.5% | $68.85 | $72.37 | $68.08 | 3,115,700 | |
| $68.79 | +2.31 | +3.5% | $67.46 | $69.26 | $66.06 | 2,347,400 | |
| $66.48 | -1.26 | -1.9% | $67.83 | $68.05 | $66.36 | 4,016,000 | |
| $67.74 | +1.95 | +3.0% | $68.91 | $68.91 | $67.00 | 3,210,100 | |
| $65.79 | -4.88 | -6.9% | $70.41 | $71.93 | $64.50 | 5,111,900 | |
| $70.67 | -10.00 | -12.4% | $82.89 | $83.55 | $70.61 | 4,369,900 | |
| $80.67 | -2.18 | -2.6% | $82.98 | $83.27 | $79.93 | 1,329,200 | |
| $82.85 | +0.09 | +0.1% | $83.75 | $85.98 | $82.36 | 1,335,800 | |
| $82.76 | +0.13 | +0.2% | $81.58 | $83.38 | $80.33 | 1,020,300 | |
| $82.63 | -2.48 | -2.9% | $84.65 | $87.20 | $82.16 | 3,668,200 | |
| $85.11 | -1.23 | -1.4% | $84.22 | $86.96 | $83.54 | 1,567,700 | |
| $86.34 | -0.15 | -0.2% | $85.87 | $86.96 | $84.20 | 757,600 | |
| $86.49 | +1.12 | +1.3% | $85.18 | $86.79 | $83.46 | 1,370,500 | |
| $85.37 | +2.63 | +3.2% | $82.87 | $85.47 | $82.09 | 1,525,400 | |
| $82.74 | +0.35 | +0.4% | $81.14 | $83.27 | $80.76 | 1,330,600 | |
| $82.39 | -2.52 | -3.0% | $83.13 | $83.76 | $80.75 | 1,595,500 | |
| $84.91 | -3.68 | -4.2% | $87.99 | $88.25 | $84.20 | 1,282,200 | |
| $88.59 | -0.53 | -0.6% | $89.59 | $89.59 | $88.06 | 857,500 | |
| $89.12 | +0.24 | +0.3% | $88.45 | $89.83 | $86.80 | 859,500 | |
| $88.88 | +2.15 | +2.5% | $88.00 | $90.21 | $87.00 | 983,000 | |
| $86.73 | -0.38 | -0.4% | $86.77 | $87.01 | $85.50 | 1,104,400 | |
| $87.11 | -0.36 | -0.4% | $87.90 | $88.46 | $85.94 | 1,089,800 | |
| $87.47 | -1.94 | -2.2% | $88.23 | $88.45 | $85.90 | 896,800 | |
| $89.41 | +1.51 | +1.7% | $89.51 | $90.00 | $87.58 | 1,363,400 | |
| $87.90 | -0.80 | -0.9% | $87.72 | $88.35 | $85.98 | 975,000 | |
| $88.70 | +2.06 | +2.4% | $86.44 | $88.94 | $86.26 | 929,700 | |
| $86.64 | +1.05 | +1.2% | $84.75 | $87.17 | $83.78 | 818,000 | |
| $85.59 | -1.66 | -1.9% | $87.60 | $88.06 | $84.76 | 1,101,900 | |
| $87.25 | -1.99 | -2.2% | $89.09 | $90.61 | $87.16 | 1,119,600 | |
| $89.24 | +0.91 | +1.0% | $88.94 | $90.97 | $88.45 | 1,042,500 | |
| $88.33 | +0.68 | +0.8% | $87.56 | $88.88 | $86.50 | 854,100 | |
| $87.65 | +1.82 | +2.1% | $88.00 | $88.67 | $86.48 | 948,300 | |
| $85.83 | -1.08 | -1.2% | $86.48 | $87.82 | $85.19 | 1,051,300 | |
| $86.91 | -2.68 | -3.0% | $87.49 | $90.81 | $85.98 | 1,703,400 | |
| $89.59 | +3.58 | +4.2% | $87.00 | $89.67 | $86.33 | 2,031,100 | |
| $86.01 | +1.36 | +1.6% | $84.82 | $86.01 | $81.61 | 1,268,600 | |
| $84.65 | -2.67 | -3.1% | $86.93 | $87.10 | $84.53 | 1,657,400 | |
| $87.32 | +1.10 | +1.3% | $87.61 | $88.16 | $85.19 | 1,367,200 | |
| $86.22 | +0.44 | +0.5% | $85.56 | $87.89 | $84.34 | 1,807,700 | |
| $85.78 | +0.25 | +0.3% | $86.31 | $86.64 | $82.77 | 1,694,500 | |
| $85.53 | -0.07 | -0.1% | $85.77 | $87.93 | $85.21 | 2,444,000 | |
| $85.60 | -1.18 | -1.4% | $86.84 | $87.50 | $85.06 | 1,825,200 | |
| $86.78 | -1.92 | -2.2% | $88.72 | $89.15 | $86.26 | 2,479,800 | |
| $88.70 | +14.18 | +19.0% | $85.46 | $95.49 | $84.34 | 6,990,900 | |
| $74.52 | +2.87 | +4.0% | $72.81 | $74.70 | $72.62 | 1,612,500 | |
| $71.65 | -2.65 | -3.6% | $74.35 | $75.06 | $71.00 | 2,410,700 |
- Ticker
- NASDAQ:ARWR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers
Latest earnings call · Aug 4, 2026
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 14, 2026
Technical Presentation (October 2026)
Technical · 47 slides
Calls
Replays
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Q3 2026 Earnings Call
Tue, Aug 04, 2026 · 4:30 PM ET
Watch TranscriptArrowhead Pharmaceuticals (NASDAQ:ARWR) Q2 2026 Earnings Call
Thu, May 07, 2026 · 4:30 PM ET
Watch TranscriptArrowhead Pharmaceuticals (NASDAQ:ARWR) Q1 2026 Earnings Call
Thu, Feb 05, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers
Oct 14, 2026
Closed $58.37 (+0.4%) on Oct 14, 2026
Arrowhead Pharmaceuticals Granted Entry in the FDA STAR Pilot Program for Plozasiran in Severe Hypertriglyceridemia
Oct 7, 2026
Closed $61.48 (-0.1%) on Oct 7, 2026
Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
Sep 29, 2026
Closed $66.25 (+1.2%) on Sep 29, 2026
Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
Sep 15, 2026
Closed $70.67 (-12.4%) on Sep 15, 2026
Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences
Sep 3, 2026
Closed $86.49 (+1.3%) on Sep 3, 2026
Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia
Aug 30, 2026
Closed $82.39 (-3.0%) on Aug 31, 2026
Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of Cardiology Congress
Aug 24, 2026
Closed $86.73 (-0.4%) on Aug 24, 2026
Arrowhead Pharmaceuticals - People Living with Familial Chylomicronaemia Syndrome in Germany Have Access to REDEMPLO as a New Treatment Option to Reduce Triglycerides
Aug 18, 2026
Closed $87.90 (-0.9%) on Aug 18, 2026
People Living with Familial Chylomicronaemia Syndrome (FCS) in Germany Have Access to REDEMPLO® (plozasiran) as a New Treatment Option to Reduce Triglycerides
Aug 17, 2026
Closed $88.70 (+2.4%) on Aug 17, 2026
Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results
Aug 4, 2026
Closed $86.91 (-3.0%) on Aug 5, 2026
Decks
Technical Presentation (October 2026)
Technical · 47 slides · Oct 14, 2026
Technical Presentation (June 2026)
Technical · 57 slides · Jun 29, 2026
Technical Presentation (January 2026)
Technical · 65 slides · Jan 6, 2026
TIDES USA 2026
Conference · 26 slides · 2026
Arrowhead Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 52 in the last 12 months · 284 in all · newest Oct 14, 2026 · oldest 2019
- Calls
- 19 calls with a replay · 19 with a transcript · latest Aug 4, 2026
- Decks
- 13 decks · latest Oct 14, 2026
Where Arrowhead Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ARWR · Home listing · This page | NASDAQ | United States | USD |
| gettex:HDP1 | gettex | Germany | EUR |
| B3:A2RR34 | B3 | Brazil | BRL |
| LS Exchange:A2AGYB | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2AGYB | Lang & Schwarz | Germany | EUR |
| BMV:ARWR | BMV | Mexico | MXN |
| LSE:0HI3 | LSE | United Kingdom | USD |
| BOATS:ARWR | BOATS | United States | USD |
| Tradegate:HDP1 | Tradegate | Germany | EUR |
| Frankfurt:HDP1 | Frankfurt | Germany | EUR |
| Stuttgart:HDP1 | Stuttgart | Germany | EUR |
| BIVA:ARWR | BIVA | Mexico | MXN |
| BX Swiss:HDP1 | BX Swiss | Switzerland | CHF |
| Dusseldorf:HDP1 | Dusseldorf | Germany | EUR |
| Hamburg:HDP1 | Hamburg | Germany | EUR |
| Munich:HDP1 | Munich | Germany | EUR |
| Hanover:HDP1 | Hanover | Germany | EUR |
| Xetra:HDP1 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Arrowhead Pharmaceuticals, Inc.